{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "18",
                "@timestamp": "2023-01-18T05:34:17.000017-05:00",
                "@year": "2023",
                "@month": "01"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2022",
                "@month": "01"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": [
                {
                    "xocs:funding-agency-matched-string": "Chiang Mai University",
                    "xocs:funding-agency-acronym": "CMU",
                    "xocs:funding-agency": "Chiang Mai University",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100002842",
                    "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
                },
                {
                    "xocs:funding-agency-matched-string": "Thailand Research Fund",
                    "xocs:funding-agency-acronym": "TRF",
                    "xocs:funding-agency": "Thailand Research Fund",
                    "xocs:funding-id": "PHD/0114/2558",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100004396",
                    "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
                }
            ],
            "xocs:funding-addon-generated-timestamp": "2022-07-20T08:17:52.030Z",
            "xocs:funding-text": "This study was supported by Chiang Mai University and The Royal Golden Jubilee Ph.D. Program, The Thailand Research Fund (grant no. PHD/0114/2558).",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60000881",
                            "@country": "tha",
                            "city": "Chiang Mai",
                            "organization": [
                                {"$": "Department of Pharmaceutical Care"},
                                {"$": "Faculty of Pharmacy"},
                                {"$": "Chiang Mai University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60000881",
                                "@dptid": "103084327"
                            },
                            "@affiliation-instance-id": "2014306404-4f2f7e862ecce1583208752775e40fb6",
                            "ce:source-text": "Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand",
                            "@dptid": "103084327"
                        },
                        "author": [
                            {
                                "ce:given-name": "Noppaket",
                                "preferred-name": {
                                    "ce:given-name": "Noppaket",
                                    "ce:initials": "N.",
                                    "ce:surname": "Singkham",
                                    "ce:indexed-name": "Singkham N."
                                },
                                "@author-instance-id": "2014306404-aa0013cd02c1f5f0dc4cab9d9eeab31f",
                                "@seq": "1",
                                "ce:initials": "N.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Singkham",
                                "@auid": "55524284500",
                                "ce:indexed-name": "Singkham N."
                            },
                            {
                                "ce:given-name": "Baralee",
                                "preferred-name": {
                                    "ce:given-name": "Baralee",
                                    "ce:initials": "B.",
                                    "ce:surname": "Punyawudho",
                                    "ce:indexed-name": "Punyawudho B."
                                },
                                "@author-instance-id": "2014306404-c77fa720d8529ad8d128d11a5b7ef9cf",
                                "@seq": "10",
                                "ce:initials": "B.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Punyawudho",
                                "@auid": "23976628300",
                                "ce:indexed-name": "Punyawudho B."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60114221",
                            "@country": "tha",
                            "city": "Phayao",
                            "organization": [
                                {"$": "School of Pharmaceutical Sciences"},
                                {"$": "University of Phayao"}
                            ],
                            "affiliation-id": {
                                "@afid": "60114221",
                                "@dptid": "121923933"
                            },
                            "@affiliation-instance-id": "2014306404-9a4b5665def0c936c46671ee4d05acfb",
                            "ce:source-text": "School of Pharmaceutical Sciences, University of Phayao, Phayao, Thailand",
                            "@dptid": "121923933"
                        },
                        "author": [{
                            "ce:given-name": "Noppaket",
                            "preferred-name": {
                                "ce:given-name": "Noppaket",
                                "ce:initials": "N.",
                                "ce:surname": "Singkham",
                                "ce:indexed-name": "Singkham N."
                            },
                            "@author-instance-id": "2014306404-aa0013cd02c1f5f0dc4cab9d9eeab31f",
                            "@seq": "1",
                            "ce:initials": "N.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Singkham",
                            "@auid": "55524284500",
                            "ce:indexed-name": "Singkham N."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60031780",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "HIV Netherlands Australia Thailand Research Collaboration"},
                                {"$": "Thai Red Cross AIDS Research Centre"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60031780"},
                                {"@afid": "60016965"}
                            ],
                            "@affiliation-instance-id": "2014306404-54baa32f2829c9c349f9ae751aaf8893",
                            "ce:source-text": "HIV Netherlands Australia Thailand Research Collaboration, Thai Red Cross AIDS Research Centre, Bangkok, Thailand"
                        },
                        "author": [
                            {
                                "ce:given-name": "Anchalee",
                                "preferred-name": {
                                    "ce:given-name": "Anchalee",
                                    "ce:initials": "A.",
                                    "ce:surname": "Avihingsanon",
                                    "ce:indexed-name": "Avihingsanon A."
                                },
                                "@author-instance-id": "2014306404-4181d6c5552f30c451b0cb3fe5b3c6eb",
                                "@seq": "2",
                                "ce:initials": "A.",
                                "@date-locked": "2023-01-18T05:16:58.450",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Avihingsanon",
                                "@auid": "57196347321",
                                "ce:indexed-name": "Avihingsanon A."
                            },
                            {
                                "ce:given-name": "Narukjaporn",
                                "preferred-name": {
                                    "ce:given-name": "Narukjaporn",
                                    "ce:initials": "N.",
                                    "ce:surname": "Thammajaruk",
                                    "ce:indexed-name": "Thammajaruk N."
                                },
                                "@author-instance-id": "2014306404-b2a43a04c47f74822acc25ad72823cc3",
                                "@seq": "5",
                                "ce:initials": "N.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Thammajaruk",
                                "@auid": "36451572800",
                                "ce:indexed-name": "Thammajaruk N."
                            },
                            {
                                "ce:given-name": "Kiat",
                                "preferred-name": {
                                    "ce:given-name": "Kiat",
                                    "ce:initials": "K.",
                                    "ce:surname": "Ruxrungtham",
                                    "ce:indexed-name": "Ruxrungtham K."
                                },
                                "@author-instance-id": "2014306404-093142ca6660c7b7e4be655bc4b83b17",
                                "@seq": "6",
                                "ce:initials": "K.",
                                "@date-locked": "2022-05-13T01:42:56.023",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Ruxrungtham",
                                "@auid": "7004208798",
                                "ce:indexed-name": "Ruxrungtham K."
                            },
                            {
                                "ce:given-name": "Torsak",
                                "preferred-name": {
                                    "ce:given-name": "Torsak",
                                    "ce:initials": "T.",
                                    "ce:surname": "Bunupuradah",
                                    "ce:indexed-name": "Bunupuradah T."
                                },
                                "@author-instance-id": "2014306404-5e065a6d4131faf6761d7676b3a7dfdc",
                                "@seq": "7",
                                "ce:initials": "T.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Bunupuradah",
                                "@auid": "15836773400",
                                "ce:indexed-name": "Bunupuradah T."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60002620",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Tuberculosis Research Unit"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60002620",
                                    "@dptid": "126214200"
                                },
                                {"@afid": "60028190"}
                            ],
                            "@affiliation-instance-id": "2014306404-53a9c13078adaeced9526ad6323647f8",
                            "ce:source-text": "Tuberculosis Research Unit, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand",
                            "@dptid": "126214200"
                        },
                        "author": [{
                            "ce:given-name": "Anchalee",
                            "preferred-name": {
                                "ce:given-name": "Anchalee",
                                "ce:initials": "A.",
                                "ce:surname": "Avihingsanon",
                                "ce:indexed-name": "Avihingsanon A."
                            },
                            "@author-instance-id": "2014306404-4181d6c5552f30c451b0cb3fe5b3c6eb",
                            "@seq": "2",
                            "ce:initials": "A.",
                            "@date-locked": "2023-01-18T05:16:58.450",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Avihingsanon",
                            "@auid": "57196347321",
                            "ce:indexed-name": "Avihingsanon A."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60015427",
                            "@country": "usa",
                            "city": "Minneapolis",
                            "organization": [
                                {"$": "Department of Experimental and Clinical Pharmacology"},
                                {"$": "College of Pharmacy"},
                                {"$": "University of Minnesota"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60015427",
                                    "@dptid": "103798664"
                                },
                                {"@afid": "60029445"}
                            ],
                            "@affiliation-instance-id": "2014306404-642b4774b3ac2bc4bc2c7ee673d36016",
                            "ce:source-text": "Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, USA",
                            "@dptid": "103798664"
                        },
                        "author": [
                            {
                                "ce:given-name": "Richard C",
                                "preferred-name": {
                                    "ce:given-name": "Richard C.",
                                    "ce:initials": "R.C.",
                                    "ce:surname": "Brundage",
                                    "ce:indexed-name": "Brundage R.C."
                                },
                                "@author-instance-id": "2014306404-d5efb85141e2ea995cb9f215e153fb79",
                                "@seq": "3",
                                "ce:initials": "R.C.",
                                "@date-locked": "2022-03-03T02:39:56.568",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Brundage",
                                "@auid": "7003818004",
                                "ce:indexed-name": "Brundage R.C."
                            },
                            {
                                "ce:given-name": "Angela K",
                                "preferred-name": {
                                    "ce:given-name": "Angela K.",
                                    "ce:initials": "A.K.",
                                    "ce:surname": "Birnbaum",
                                    "ce:indexed-name": "Birnbaum A.K."
                                },
                                "@author-instance-id": "2014306404-3e342f0fc932d34847b89a00b4d146f1",
                                "@seq": "4",
                                "ce:initials": "A.K.",
                                "@date-locked": "2022-03-03T02:39:56.568",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Birnbaum",
                                "@auid": "7007017778",
                                "ce:indexed-name": "Birnbaum A.K."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60002620",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Department of Medicine"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60002620"},
                                {"@afid": "60028190"}
                            ],
                            "@affiliation-instance-id": "2014306404-ac60f2a15640e37ccfc0f73128252d8b",
                            "ce:source-text": "Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand"
                        },
                        "author": [{
                            "ce:given-name": "Kiat",
                            "preferred-name": {
                                "ce:given-name": "Kiat",
                                "ce:initials": "K.",
                                "ce:surname": "Ruxrungtham",
                                "ce:indexed-name": "Ruxrungtham K."
                            },
                            "@author-instance-id": "2014306404-093142ca6660c7b7e4be655bc4b83b17",
                            "@seq": "6",
                            "ce:initials": "K.",
                            "@date-locked": "2022-05-13T01:42:56.023",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Ruxrungtham",
                            "@auid": "7004208798",
                            "ce:indexed-name": "Ruxrungtham K."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60015887",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Faculty of Medicine Ramathibodi Hospital"},
                                {"$": "Mahidol University"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60015887"},
                                {"@afid": "60012718"}
                            ],
                            "@affiliation-instance-id": "2014306404-8b0cd39df2524acaada8f427643e96b1",
                            "ce:source-text": "Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand"
                        },
                        "author": [{
                            "ce:given-name": "Sasisopin",
                            "preferred-name": {
                                "ce:given-name": "Sasisopin",
                                "ce:initials": "S.",
                                "ce:surname": "Kiertiburanakul",
                                "ce:indexed-name": "Kiertiburanakul S."
                            },
                            "@author-instance-id": "2014306404-224b8e7f47497b07808a5e32a0973080",
                            "@seq": "8",
                            "ce:initials": "S.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Kiertiburanakul",
                            "@auid": "6506539792",
                            "ce:indexed-name": "Kiertiburanakul S."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60026046",
                            "@country": "tha",
                            "city": "Khon Kaen",
                            "organization": [
                                {"$": "Faculty of Medicine"},
                                {"$": "Khon Kaen University"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60026046"},
                                {"@afid": "60017165"}
                            ],
                            "@affiliation-instance-id": "2014306404-d235aee825d4e91b1171977c1c98897f",
                            "ce:source-text": "Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand"
                        },
                        "author": [{
                            "ce:given-name": "Ploenchan",
                            "preferred-name": {
                                "ce:given-name": "Ploenchan",
                                "ce:initials": "P.",
                                "ce:surname": "Chetchotisakd",
                                "ce:indexed-name": "Chetchotisakd P."
                            },
                            "@author-instance-id": "2014306404-0b493c625123479cfb7ba4f8d4c9b34c",
                            "@seq": "9",
                            "ce:initials": "P.",
                            "@date-locked": "2022-12-16T05:05:30.157",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Chetchotisakd",
                            "@auid": "56992885200",
                            "ce:indexed-name": "Chetchotisakd P."
                        }]
                    },
                    {"collaboration": {
                        "@seq": "11",
                        "@collaboration-instance-id": "2014306404-1dd94e9e6792e39679d6c3c315d897c9",
                        "ce:text": "LASA study team",
                        "ce:indexed-name": "LASA study team"
                    }}
                ],
                "citation-title": "Pharmacogenetics-based population pharmacokinetic analysis for dose optimization of ritonavir-boosted atazanavir in Thai adult HIV-infected patients",
                "abstracts": "© 2021 Informa UK Limited, trading as Taylor & Francis Group.Background: This population pharmacokinetic\u2013pharmacogenetic study aimed to investigate the optimal dose of RTV-boosted ATV (ATV/RTV) for Thai adult HIV-infected patients. Methods: A total of 1460 concentrations of ATV and RTV from 544 patients receiving an ATV/RTV-based regimen were analyzed. The CYP3A5 6986 A > G, ABCB1 3435 C > T, ABCB1 2677 G > T, SLCO1B1 521 T > C, and NR1I2 63396 C > T were genotyped. A population pharmacokinetic model was performed using a nonlinear mixed-effect model (NONMEM®). Monte Carlo simulations were conducted to compare the percentages of patients achieving the therapeutic range of ATV through concentrations (Ctrough). Results: The apparent oral clearance of ATV (CL/FATV) without RTV was 7.69 L/h with interindividual variability (IIV) of 28.7%. Patients with CYP3A5 6986 GG had a 7.1% lower CL/FATV than those with AA or AG genotype. The CL/FATV decreased by 10.8% for females compared with males. Simulation results showed higher percentages (~70%) of patient receiving doses of 200/100 or 200/50 mg achieved the target ATV Ctrough, while more patients (~40%) receiving a standard dose (300/100 mg) had ATV Ctrough above this target. Conclusions: Both CYP3A5 6986 A > G and female decreased CL/FATV in Thai HIV-infected patients. Simulations supported that the reduced dose of ATV/RTV was sufficient to achieve the target concentration for Thai population.",
                "correspondence": {
                    "affiliation": {
                        "country": "Thailand",
                        "@country": "tha",
                        "city": "Chiang Mai",
                        "organization": [
                            {"$": "Department of Pharmaceutical Care"},
                            {"$": "Faculty of Pharmacy"},
                            {"$": "Chiang Mai University"}
                        ],
                        "ce:source-text": "Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand"
                    },
                    "person": {
                        "ce:given-name": "Baralee",
                        "ce:initials": "B.",
                        "ce:surname": "Punyawudho",
                        "ce:indexed-name": "Punyawudho B."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "Atazanavir",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Pharmacogenetics",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Population Pharmacokinetics",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Ritonavir",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Thai patient",
                            "@xml:lang": "eng",
                            "@original": "y"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "sourcetitle-abbrev": "Expert Rev. Clin. Pharmacol.",
                    "website": {"ce:e-address": {
                        "$": "https://www.tandfonline.com/loi/ierj20",
                        "@type": "email"
                    }},
                    "@country": "gbr",
                    "translated-sourcetitle": {
                        "$": "Expert Review of Clinical Pharmacology",
                        "@xml:lang": "eng"
                    },
                    "issn": [
                        {
                            "$": "17512441",
                            "@type": "electronic"
                        },
                        {
                            "$": "17512433",
                            "@type": "print"
                        }
                    ],
                    "volisspag": {
                        "voliss": {
                            "@volume": "15",
                            "@issue": "1"
                        },
                        "pagerange": {
                            "@first": "99",
                            "@last": "108"
                        }
                    },
                    "@type": "j",
                    "publicationyear": {"@first": "2022"},
                    "publisher": {"publishername": "Taylor and Francis Ltd."},
                    "sourcetitle": "Expert Review of Clinical Pharmacology",
                    "@srcid": "10300153301",
                    "publicationdate": {
                        "year": "2022",
                        "date-text": {
                            "@xfab-added": "true",
                            "$": "2022"
                        }
                    }
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "29",
                                    "classification-description": "Clinical and Experimental Biochemistry"
                                },
                                {
                                    "classification-code": "30",
                                    "classification-description": "Clinical and Experimental Pharmacology"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                },
                                {
                                    "classification-code": "4",
                                    "classification-description": "Microbiology: Bacteriology, Mycology, Parasitology and Virology"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": [
                                {"$": "3000"},
                                {"$": "2736"}
                            ]
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": [
                                {"$": "PHAR"},
                                {"$": "MEDI"}
                            ]
                        }
                    ]},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": [
                                {
                                    "cas-registry-number": "336874-97-6",
                                    "chemical-name": "cytochrome P450 3A5"
                                },
                                {
                                    "cas-registry-number": "67254-75-5",
                                    "chemical-name": "protein"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "202138-50-9"},
                                        {"$": "1637632-97-3"},
                                        {"$": "1453166-76-1"},
                                        {"$": "201341-05-1"}
                                    ],
                                    "chemical-name": "tenofovir disoproxil"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "198904-31-3"},
                                        {"$": "229975-97-7"}
                                    ],
                                    "chemical-name": "atazanavir"
                                },
                                {
                                    "cas-registry-number": "155213-67-5",
                                    "chemical-name": "ritonavir"
                                }
                            ]
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "Anti-HIV Agents"},
                                {"chemical-name": "Atazanavir Sulfate"},
                                {"chemical-name": "Liver-Specific Organic Anion Transporter 1"},
                                {"chemical-name": "Ritonavir"},
                                {"chemical-name": "SLCO1B1 protein, human"}
                            ]
                        }
                    ]}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "This study was supported by Chiang Mai University and The Royal Golden Jubilee Ph.D. Program, The Thailand Research Fund (grant no. PHD/0114/2558).",
                        "@xml:lang": "eng"
                    }
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2022 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "MEDLINE",
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "15",
                    "@timestamp": "BST 03:28:09",
                    "@year": "2022",
                    "@month": "10"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2014306404",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "937009249",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20211102980",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "34727835",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "20214788375",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20214013056",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "20219013212521",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85120038365",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85120038365",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "636679724",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "79154999",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:doi": "10.1080/17512433.2022.2000858"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "56",
                "reference": [
                    {
                        "ref-fulltext": "Panel on antiretroviral guidelines for adults and adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Department of health and human services; 2021 [cited 2021 Jun]. Available from: https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/AdultandAdolescentGL.pdf",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/AdultandAdolescentGL.pdf",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Guidelines for the use of antiretroviral agents in adults and adolescents with HIV"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85120082122",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "cited, 2021 Jun, Available from",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "Panel on antiretroviral guidelines for adults and adolescents",
                                "ce:indexed-name": "Panel on antiretroviral guidelines for adults and adolescents"
                            }},
                            "ref-sourcetitle": "Department of health and human services"
                        },
                        "ce:source-text": "Panel on antiretroviral guidelines for adults and adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Department of health and human services; 2021 [cited 2021 Jun]. Available from: https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/AdultandAdolescentGL.pdf"
                    },
                    {
                        "ref-fulltext": "Thailand national guidelines on HIV/AIDS treatment and prevention bureau of AIDS, TB and STIs department of disease control, ministry of public health. 2017 [cited 2019 Dec]. Available from: http://www.thaiaidssociety.org/images/PDF/hiv_thai_guideline_2560.pdf",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-website": {"ce:e-address": {
                                "$": "http://www.thaiaidssociety.org/images/PDF/hiv_thai_guideline_2560.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0002",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85120059220",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "cited, 2019 Dec, Available from"
                        },
                        "ce:source-text": "Thailand national guidelines on HIV/AIDS treatment and prevention bureau of AIDS, TB and STIs department of disease control, ministry of public health. 2017 [cited 2019 Dec]. Available from: http://www.thaiaidssociety.org/images/PDF/hiv_thai_guideline_2560.pdf"
                    },
                    {
                        "ref-fulltext": "Croom KF, Dhillon S, and Keam SJ., et al. Atazanavir: a review of its use in the management of HIV-1 infection. Drugs. 2009 May 29; 69 (8): 1107\u20131140.",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Atazanavir: a review of its use in the management of HIV-1 infection"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0003",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "67049086180",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "69",
                                    "@issue": "8"
                                },
                                "pagerange": {
                                    "@first": "1107",
                                    "@last": "1140"
                                }
                            },
                            "ref-text": "May, 29, and",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "K.F.",
                                        "@_fa": "true",
                                        "ce:surname": "Croom",
                                        "ce:indexed-name": "Croom K.F."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Dhillon",
                                        "ce:indexed-name": "Dhillon S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Keam",
                                        "ce:indexed-name": "Keam S.J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Drugs"
                        },
                        "ce:source-text": "Croom KF, Dhillon S, and Keam SJ., et al. Atazanavir: a review of its use in the management of HIV-1 infection. Drugs. 2009 May 29; 69 (8): 1107\u20131140."
                    },
                    {
                        "ref-fulltext": "Le TC, Barrail A, Goujard C, et al. Clinical pharmacokinetics and summary of efficacy and tolerability of atazanavir. Clin Pharmacokinet. 2005; 44 (10): 1035\u20131050.",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Clinical pharmacokinetics and summary of efficacy and tolerability of atazanavir"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0004",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "25144448034",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "44",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "1035",
                                    "@last": "1050"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Le",
                                        "ce:indexed-name": "Le T.C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Barrail",
                                        "ce:indexed-name": "Barrail A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Goujard",
                                        "ce:indexed-name": "Goujard C."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Pharmacokinet"
                        },
                        "ce:source-text": "Le TC, Barrail A, Goujard C, et al. Clinical pharmacokinetics and summary of efficacy and tolerability of atazanavir. Clin Pharmacokinet. 2005; 44 (10): 1035\u20131050."
                    },
                    {
                        "ref-fulltext": "Griffin L, Annaert P, Brouwer KL., et al. Influence of drug transport proteins on the pharmacokinetics and drug interactions of HIV protease inhibitors. J Pharm Sci. 2011 Sep; 100 (9): 3636\u20133654.",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Influence of drug transport proteins on the pharmacokinetics and drug interactions of HIV protease inhibitors"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0005",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "79960133743",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "100",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "3636",
                                    "@last": "3654"
                                }
                            },
                            "ref-text": "Sep",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Griffin",
                                        "ce:indexed-name": "Griffin L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Annaert",
                                        "ce:indexed-name": "Annaert P."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Brouwer",
                                        "ce:indexed-name": "Brouwer K.L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Pharm Sci"
                        },
                        "ce:source-text": "Griffin L, Annaert P, Brouwer KL., et al. Influence of drug transport proteins on the pharmacokinetics and drug interactions of HIV protease inhibitors. J Pharm Sci. 2011 Sep; 100 (9): 3636\u20133654."
                    },
                    {
                        "ref-fulltext": "Larson KB, Wang K, Delille C, et al. Pharmacokinetic enhancers in HIV therapeutics. Clin Pharmacokinet. 2014 Oct; 53 (10): 865\u2013872.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Pharmacokinetic enhancers in HIV therapeutics"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0006",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84918796678",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "53",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "865",
                                    "@last": "872"
                                }
                            },
                            "ref-text": "Oct",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "K.B.",
                                        "@_fa": "true",
                                        "ce:surname": "Larson",
                                        "ce:indexed-name": "Larson K.B."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Wang",
                                        "ce:indexed-name": "Wang K."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Delille",
                                        "ce:indexed-name": "Delille C."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Pharmacokinet"
                        },
                        "ce:source-text": "Larson KB, Wang K, Delille C, et al. Pharmacokinetic enhancers in HIV therapeutics. Clin Pharmacokinet. 2014 Oct; 53 (10): 865\u2013872."
                    },
                    {
                        "ref-fulltext": "Winston A, Bloch M, Carr A, et al. Atazanavir trough plasma concentration monitoring in a cohort of HIV-1-positive individuals receiving highly active antiretroviral therapy. J Antimicrob Chemother. 2005 Aug; 56 (2): 380\u2013387.",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Atazanavir trough plasma concentration monitoring in a cohort of HIV-1-positive individuals receiving highly active antiretroviral therapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0007",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "23844481944",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "56",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "380",
                                    "@last": "387"
                                }
                            },
                            "ref-text": "Aug",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Winston",
                                        "ce:indexed-name": "Winston A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Bloch",
                                        "ce:indexed-name": "Bloch M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Carr",
                                        "ce:indexed-name": "Carr A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Antimicrob Chemother"
                        },
                        "ce:source-text": "Winston A, Bloch M, Carr A, et al. Atazanavir trough plasma concentration monitoring in a cohort of HIV-1-positive individuals receiving highly active antiretroviral therapy. J Antimicrob Chemother. 2005 Aug; 56 (2): 380\u2013387."
                    },
                    {
                        "ref-fulltext": "Colombo S, Buclin T, Cavassini M, et al. Population pharmacokinetics of atazanavir in patients with human immunodeficiency virus infection. Antimicrob Agents Chemother. 2006 Nov; 50 (11): 3801\u20133808.",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Population pharmacokinetics of atazanavir in patients with human immunodeficiency virus infection"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0008",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "33750597597",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "50",
                                    "@issue": "11"
                                },
                                "pagerange": {
                                    "@first": "3801",
                                    "@last": "3808"
                                }
                            },
                            "ref-text": "Nov",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Colombo",
                                        "ce:indexed-name": "Colombo S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Buclin",
                                        "ce:indexed-name": "Buclin T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Cavassini",
                                        "ce:indexed-name": "Cavassini M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Antimicrob Agents Chemother"
                        },
                        "ce:source-text": "Colombo S, Buclin T, Cavassini M, et al. Population pharmacokinetics of atazanavir in patients with human immunodeficiency virus infection. Antimicrob Agents Chemother. 2006 Nov; 50 (11): 3801\u20133808."
                    },
                    {
                        "ref-fulltext": "Lamba J, Hebert JM, Schuetz EG, et al. PharmGKB summary: very important pharmacogene information for CYP3A5. Pharmacogenet Genomics. 2012 Jul; 22 (7): 555\u2013558.",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "PharmGKB summary: very important pharmacogene information for CYP3A5"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0009",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84862756288",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "22",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "555",
                                    "@last": "558"
                                }
                            },
                            "ref-text": "Jul",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Lamba",
                                        "ce:indexed-name": "Lamba J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Hebert",
                                        "ce:indexed-name": "Hebert J.M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Schuetz",
                                        "ce:indexed-name": "Schuetz E.G."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Pharmacogenet Genomics"
                        },
                        "ce:source-text": "Lamba J, Hebert JM, Schuetz EG, et al. PharmGKB summary: very important pharmacogene information for CYP3A5. Pharmacogenet Genomics. 2012 Jul; 22 (7): 555\u2013558."
                    },
                    {
                        "ref-fulltext": "Lamba JK, Lin YS, Schuetz EG, et al. Genetic contribution to variable human CYP3A-mediated metabolism. Adv Drug Deliv Rev. 2012; 64: 256\u2013269.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Genetic contribution to variable human CYP3A-mediated metabolism"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0010",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84870255195",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "64"},
                                "pagerange": {
                                    "@first": "256",
                                    "@last": "269"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.K.",
                                        "@_fa": "true",
                                        "ce:surname": "Lamba",
                                        "ce:indexed-name": "Lamba J.K."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Lin",
                                        "ce:indexed-name": "Lin Y.S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Schuetz",
                                        "ce:indexed-name": "Schuetz E.G."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Adv Drug Deliv Rev"
                        },
                        "ce:source-text": "Lamba JK, Lin YS, Schuetz EG, et al. Genetic contribution to variable human CYP3A-mediated metabolism. Adv Drug Deliv Rev. 2012; 64: 256\u2013269."
                    },
                    {
                        "ref-fulltext": "Kile DA, MaWhinney S, Aquilante CL, et al. A population pharmacokinetic-pharmacogenetic analysis of atazanavir. AIDS Res Hum Retroviruses. 2012 Oct; 28 (10): 1227\u20131234.",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "A population pharmacokinetic-pharmacogenetic analysis of atazanavir"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0011",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84866696853",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "28",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "1227",
                                    "@last": "1234"
                                }
                            },
                            "ref-text": "Oct",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Kile",
                                        "ce:indexed-name": "Kile D.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "MaWhinney",
                                        "ce:indexed-name": "MaWhinney S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Aquilante",
                                        "ce:indexed-name": "Aquilante C.L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "AIDS Res Hum Retroviruses"
                        },
                        "ce:source-text": "Kile DA, MaWhinney S, Aquilante CL, et al. A population pharmacokinetic-pharmacogenetic analysis of atazanavir. AIDS Res Hum Retroviruses. 2012 Oct; 28 (10): 1227\u20131234."
                    },
                    {
                        "ref-fulltext": "Savic RM, Barrail-Tran A, and Duval X, et al. Effect of adherence as measured by MEMS, ritonavir boosting, and CYP3A5 genotype on atazanavir pharmacokinetics in treatment-naive HIV-infected patients. Clin Pharmacol Ther. 2012 Nov; 92 (5): 575\u2013583.",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Effect of adherence as measured by MEMS, ritonavir boosting, and CYP3A5 genotype on atazanavir pharmacokinetics in treatment-naive HIV-infected patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0012",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84867883813",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "92",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "575",
                                    "@last": "583"
                                }
                            },
                            "ref-text": "Nov, and",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Savic",
                                        "ce:indexed-name": "Savic R.M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Barrail-Tran",
                                        "ce:indexed-name": "Barrail-Tran A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "X.",
                                        "@_fa": "true",
                                        "ce:surname": "Duval",
                                        "ce:indexed-name": "Duval X."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Pharmacol Ther"
                        },
                        "ce:source-text": "Savic RM, Barrail-Tran A, and Duval X, et al. Effect of adherence as measured by MEMS, ritonavir boosting, and CYP3A5 genotype on atazanavir pharmacokinetics in treatment-naive HIV-infected patients. Clin Pharmacol Ther. 2012 Nov; 92 (5): 575\u2013583."
                    },
                    {
                        "ref-fulltext": "Anderson PL, Aquilante CL, and Gardner EM, et al. Atazanavir pharmacokinetics in genetically determined CYP3A5 expressors versus non-expressors. J Antimicrob Chemother. 2009 Nov; 64 (5): 1071\u20131079.",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Atazanavir pharmacokinetics in genetically determined CYP3A5 expressors versus non-expressors"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0013",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "73949129834",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "64",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "1071",
                                    "@last": "1079"
                                }
                            },
                            "ref-text": "Nov, and",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Anderson",
                                        "ce:indexed-name": "Anderson P.L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Aquilante",
                                        "ce:indexed-name": "Aquilante C.L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Gardner",
                                        "ce:indexed-name": "Gardner E.M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Antimicrob Chemother"
                        },
                        "ce:source-text": "Anderson PL, Aquilante CL, and Gardner EM, et al. Atazanavir pharmacokinetics in genetically determined CYP3A5 expressors versus non-expressors. J Antimicrob Chemother. 2009 Nov; 64 (5): 1071\u20131079."
                    },
                    {
                        "ref-fulltext": "Singkham N, Avihingsanon A, Thammajaruk N, et al. Influence of CYP3A5 and SLCO1B1 polymorphisms on atazanavir/r concentrations in Thai HIV-infected patients. Pharmacogenomics. 2019 May; 20 (7): 517\u2013527.",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Influence of CYP3A5 and SLCO1B1 polymorphisms on atazanavir/r concentrations in Thai HIV-infected patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0014",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85066117677",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "20",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "517",
                                    "@last": "527"
                                }
                            },
                            "ref-text": "May",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Singkham",
                                        "ce:indexed-name": "Singkham N."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Avihingsanon",
                                        "ce:indexed-name": "Avihingsanon A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Thammajaruk",
                                        "ce:indexed-name": "Thammajaruk N."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Pharmacogenomics"
                        },
                        "ce:source-text": "Singkham N, Avihingsanon A, Thammajaruk N, et al. Influence of CYP3A5 and SLCO1B1 polymorphisms on atazanavir/r concentrations in Thai HIV-infected patients. Pharmacogenomics. 2019 May; 20 (7): 517\u2013527."
                    },
                    {
                        "ref-fulltext": "Wolking S, Schaeffeler E, Lerche H, et al. Impact of genetic polymorphisms of ABCB1 (MDR1, P-glycoprotein) on drug disposition and potential clinical implications: update of the literature. Clin Pharmacokinet. 2015 Jul; 54 (7): 709\u2013735.",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Impact of genetic polymorphisms of ABCB1 (MDR1, P-glycoprotein) on drug disposition and potential clinical implications: update of the literature"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0015",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84933673958",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "54",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "709",
                                    "@last": "735"
                                }
                            },
                            "ref-text": "Jul",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Wolking",
                                        "ce:indexed-name": "Wolking S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Schaeffeler",
                                        "ce:indexed-name": "Schaeffeler E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Lerche",
                                        "ce:indexed-name": "Lerche H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Pharmacokinet"
                        },
                        "ce:source-text": "Wolking S, Schaeffeler E, Lerche H, et al. Impact of genetic polymorphisms of ABCB1 (MDR1, P-glycoprotein) on drug disposition and potential clinical implications: update of the literature. Clin Pharmacokinet. 2015 Jul; 54 (7): 709\u2013735."
                    },
                    {
                        "ref-fulltext": "Alam C, Whyte-Allman SK, Omeragic A, et al. Role and modulation of drug transporters in HIV-1 therapy. Adv Drug Deliv Rev. 2016 Aug 01; 103: 121\u2013143.",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Role and modulation of drug transporters in HIV-1 therapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0016",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84975496953",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "103"},
                                "pagerange": {
                                    "@first": "121",
                                    "@last": "143"
                                }
                            },
                            "ref-text": "Aug, 01",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Alam",
                                        "ce:indexed-name": "Alam C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.K.",
                                        "@_fa": "true",
                                        "ce:surname": "Whyte-Allman",
                                        "ce:indexed-name": "Whyte-Allman S.K."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Omeragic",
                                        "ce:indexed-name": "Omeragic A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Adv Drug Deliv Rev"
                        },
                        "ce:source-text": "Alam C, Whyte-Allman SK, Omeragic A, et al. Role and modulation of drug transporters in HIV-1 therapy. Adv Drug Deliv Rev. 2016 Aug 01; 103: 121\u2013143."
                    },
                    {
                        "ref-fulltext": "Rodriguez NS, Barreiro P, Rendon A, et al. Plasma levels of atazanavir and the risk of hyperbilirubinemia are predicted by the 3435C\u2013>T polymorphism at the multidrug resistance gene 1. Clin Infect Dis. 2006 Jan 15; 42 (2): 291\u2013295.",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Plasma levels of atazanavir and the risk of hyperbilirubinemia are predicted by the 3435C\u2013>T polymorphism at the multidrug resistance gene 1"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0017",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "30144438738",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "42",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "291",
                                    "@last": "295"
                                }
                            },
                            "ref-text": "Jan, 15",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Rodriguez",
                                        "ce:indexed-name": "Rodriguez N.S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Barreiro",
                                        "ce:indexed-name": "Barreiro P."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Rendon",
                                        "ce:indexed-name": "Rendon A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Infect Dis"
                        },
                        "ce:source-text": "Rodriguez NS, Barreiro P, Rendon A, et al. Plasma levels of atazanavir and the risk of hyperbilirubinemia are predicted by the 3435C\u2013>T polymorphism at the multidrug resistance gene 1. Clin Infect Dis. 2006 Jan 15; 42 (2): 291\u2013295."
                    },
                    {
                        "ref-fulltext": "Rodriguez NS, Martin-Carbonero L, and Barreiro P, et al. Genetic factors influencing atazanavir plasma concentrations and the risk of severe hyperbilirubinemia. Aids. 2007 Jan 02; 21 (1): 41\u201346.",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Genetic factors influencing atazanavir plasma concentrations and the risk of severe hyperbilirubinemia"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0018",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "33845495422",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "21",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "41",
                                    "@last": "46"
                                }
                            },
                            "ref-text": "Jan, 02, and",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Rodriguez",
                                        "ce:indexed-name": "Rodriguez N.S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Martin-Carbonero",
                                        "ce:indexed-name": "Martin-Carbonero L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Barreiro",
                                        "ce:indexed-name": "Barreiro P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Aids"
                        },
                        "ce:source-text": "Rodriguez NS, Martin-Carbonero L, and Barreiro P, et al. Genetic factors influencing atazanavir plasma concentrations and the risk of severe hyperbilirubinemia. Aids. 2007 Jan 02; 21 (1): 41\u201346."
                    },
                    {
                        "ref-fulltext": "D\u2019Avolio A, Carcieri C, Cusato J, et al. Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphisms. J Antimicrob Chemother. 2014 Nov; 69 (11): 3061\u20133066.",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphisms"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0019",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84923065347",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "69",
                                    "@issue": "11"
                                },
                                "pagerange": {
                                    "@first": "3061",
                                    "@last": "3066"
                                }
                            },
                            "ref-text": "Nov",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "D\u2019Avolio",
                                        "ce:indexed-name": "D'Avolio A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Carcieri",
                                        "ce:indexed-name": "Carcieri C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Cusato",
                                        "ce:indexed-name": "Cusato J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Antimicrob Chemother"
                        },
                        "ce:source-text": "D\u2019Avolio A, Carcieri C, Cusato J, et al. Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphisms. J Antimicrob Chemother. 2014 Nov; 69 (11): 3061\u20133066."
                    },
                    {
                        "ref-fulltext": "Avihingsanon A, Tongkobpetch S, Kerr SJ, et al. Pharmacogenetic testing can identify patients taking atazanavir at risk for hyperbilirubinemia. J Acquir Immune Defic Syndr. 2015 May 1; 69 (1): e36\u201337.",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Pharmacogenetic testing can identify patients taking atazanavir at risk for hyperbilirubinemia"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0020",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84928422012",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "69",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "e36",
                                    "@last": "e37"
                                }
                            },
                            "ref-text": "May, 1",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Avihingsanon",
                                        "ce:indexed-name": "Avihingsanon A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Tongkobpetch",
                                        "ce:indexed-name": "Tongkobpetch S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Kerr",
                                        "ce:indexed-name": "Kerr S.J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Acquir Immune Defic Syndr"
                        },
                        "ce:source-text": "Avihingsanon A, Tongkobpetch S, Kerr SJ, et al. Pharmacogenetic testing can identify patients taking atazanavir at risk for hyperbilirubinemia. J Acquir Immune Defic Syndr. 2015 May 1; 69 (1): e36\u201337."
                    },
                    {
                        "ref-fulltext": "Rakhmanina NY, Neely MN, Van Schaik RH, et al. CYP3A5, ABCB1, and SLCO1B1 polymorphisms and pharmacokinetics and virologic outcome of lopinavir/ritonavir in HIV-infected children. Ther Drug Monit. 2011 Aug; 33 (4): 417\u2013424.",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "CYP3A5, ABCB1, and SLCO1B1 polymorphisms and pharmacokinetics and virologic outcome of lopinavir/ritonavir in HIV-infected children"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0021",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "80051792323",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "33",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "417",
                                    "@last": "424"
                                }
                            },
                            "ref-text": "Aug",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N.Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Rakhmanina",
                                        "ce:indexed-name": "Rakhmanina N.Y."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.N.",
                                        "@_fa": "true",
                                        "ce:surname": "Neely",
                                        "ce:indexed-name": "Neely M.N."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Van Schaik",
                                        "ce:indexed-name": "Van Schaik R.H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ther Drug Monit"
                        },
                        "ce:source-text": "Rakhmanina NY, Neely MN, Van Schaik RH, et al. CYP3A5, ABCB1, and SLCO1B1 polymorphisms and pharmacokinetics and virologic outcome of lopinavir/ritonavir in HIV-infected children. Ther Drug Monit. 2011 Aug; 33 (4): 417\u2013424."
                    },
                    {
                        "ref-fulltext": "Ihunnah CA, Jiang M, and Xie W., et al. Nuclear receptor PXR, transcriptional circuits and metabolic relevance. Biochim Biophys Acta. 2011 Aug; 1812 (8): 956\u2013963.",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Nuclear receptor PXR, transcriptional circuits and metabolic relevance"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0022",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "79958268830",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "1812",
                                    "@issue": "8"
                                },
                                "pagerange": {
                                    "@first": "956",
                                    "@last": "963"
                                }
                            },
                            "ref-text": "Aug, and",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Ihunnah",
                                        "ce:indexed-name": "Ihunnah C.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Jiang",
                                        "ce:indexed-name": "Jiang M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "W.",
                                        "@_fa": "true",
                                        "ce:surname": "Xie",
                                        "ce:indexed-name": "Xie W."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Biochim Biophys Acta"
                        },
                        "ce:source-text": "Ihunnah CA, Jiang M, and Xie W., et al. Nuclear receptor PXR, transcriptional circuits and metabolic relevance. Biochim Biophys Acta. 2011 Aug; 1812 (8): 956\u2013963."
                    },
                    {
                        "ref-fulltext": "Siccardi M, D\u2019Avolio A, Baietto L, et al. Association of a single-nucleotide polymorphism in the pregnane X receptor (PXR 63396C→ T) with reduced concentrations of unboosted atazanavir. Clin Infect Dis. 2008; 47 (9): 1222\u20131225.",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Association of a single-nucleotide polymorphism in the pregnane X receptor (PXR 63396C→ T) with reduced concentrations of unboosted atazanavir"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0023",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "53349160769",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "47",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "1222",
                                    "@last": "1225"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Siccardi",
                                        "ce:indexed-name": "Siccardi M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "D\u2019Avolio",
                                        "ce:indexed-name": "D'Avolio A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Baietto",
                                        "ce:indexed-name": "Baietto L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Infect Dis"
                        },
                        "ce:source-text": "Siccardi M, D\u2019Avolio A, Baietto L, et al. Association of a single-nucleotide polymorphism in the pregnane X receptor (PXR 63396C→ T) with reduced concentrations of unboosted atazanavir. Clin Infect Dis. 2008; 47 (9): 1222\u20131225."
                    },
                    {
                        "ref-fulltext": "Schipani A, Siccardi M, D\u2019Avolio A, et al. Population pharmacokinetic modeling of the association between 63396C->T pregnane X receptor polymorphism and unboosted atazanavir clearance. Antimicrob Agents Chemother. 2010 Dec; 54 (12): 5242\u20135250.",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Population pharmacokinetic modeling of the association between 63396C->T pregnane X receptor polymorphism and unboosted atazanavir clearance"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0024",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "78649673343",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "54",
                                    "@issue": "12"
                                },
                                "pagerange": {
                                    "@first": "5242",
                                    "@last": "5250"
                                }
                            },
                            "ref-text": "Dec",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Schipani",
                                        "ce:indexed-name": "Schipani A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Siccardi",
                                        "ce:indexed-name": "Siccardi M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "D\u2019Avolio",
                                        "ce:indexed-name": "D'Avolio A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Antimicrob Agents Chemother"
                        },
                        "ce:source-text": "Schipani A, Siccardi M, D\u2019Avolio A, et al. Population pharmacokinetic modeling of the association between 63396C->T pregnane X receptor polymorphism and unboosted atazanavir clearance. Antimicrob Agents Chemother. 2010 Dec; 54 (12): 5242\u20135250."
                    },
                    {
                        "ref-fulltext": "Winston A, Jose S, Gibbons S, et al. Effects of age on antiretroviral plasma drug concentration in HIV-infected subjects undergoing routine therapeutic drug monitoring. J Antimicrob Chemother. 2013 Jun; 68 (6): 1354\u20131359.",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Effects of age on antiretroviral plasma drug concentration in HIV-infected subjects undergoing routine therapeutic drug monitoring"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0025",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84883244574",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "68",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "1354",
                                    "@last": "1359"
                                }
                            },
                            "ref-text": "Jun",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Winston",
                                        "ce:indexed-name": "Winston A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Jose",
                                        "ce:indexed-name": "Jose S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Gibbons",
                                        "ce:indexed-name": "Gibbons S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Antimicrob Chemother"
                        },
                        "ce:source-text": "Winston A, Jose S, Gibbons S, et al. Effects of age on antiretroviral plasma drug concentration in HIV-infected subjects undergoing routine therapeutic drug monitoring. J Antimicrob Chemother. 2013 Jun; 68 (6): 1354\u20131359."
                    },
                    {
                        "ref-fulltext": "Punyawudho B, Thammajaruk N, and Ruxrungtham K, et al. Population pharmacokinetics and dose optimisation of ritonavir-boosted atazanavir in Thai HIV-infected patients. Int J Antimicrob Agents. 2017 Mar; 49 (3): 327\u2013332.",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Population pharmacokinetics and dose optimisation of ritonavir-boosted atazanavir in Thai HIV-infected patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0026",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85011066657",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "49",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "327",
                                    "@last": "332"
                                }
                            },
                            "ref-text": "Mar, and",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Punyawudho",
                                        "ce:indexed-name": "Punyawudho B."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Thammajaruk",
                                        "ce:indexed-name": "Thammajaruk N."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Ruxrungtham",
                                        "ce:indexed-name": "Ruxrungtham K."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Int J Antimicrob Agents"
                        },
                        "ce:source-text": "Punyawudho B, Thammajaruk N, and Ruxrungtham K, et al. Population pharmacokinetics and dose optimisation of ritonavir-boosted atazanavir in Thai HIV-infected patients. Int J Antimicrob Agents. 2017 Mar; 49 (3): 327\u2013332."
                    },
                    {
                        "ref-fulltext": "Amadasi S, Odolini S, Foca E, et al. Evaluation of boosted and unboosted atazanavir plasma concentration in HIV infected patients. Curr HIV Res. 2013 Dec; 11 (8): 642\u2013646.",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Evaluation of boosted and unboosted atazanavir plasma concentration in HIV infected patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0027",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84900469083",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "11",
                                    "@issue": "8"
                                },
                                "pagerange": {
                                    "@first": "642",
                                    "@last": "646"
                                }
                            },
                            "ref-text": "Dec",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Amadasi",
                                        "ce:indexed-name": "Amadasi S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Odolini",
                                        "ce:indexed-name": "Odolini S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Foca",
                                        "ce:indexed-name": "Foca E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Curr HIV Res"
                        },
                        "ce:source-text": "Amadasi S, Odolini S, Foca E, et al. Evaluation of boosted and unboosted atazanavir plasma concentration in HIV infected patients. Curr HIV Res. 2013 Dec; 11 (8): 642\u2013646."
                    },
                    {
                        "ref-fulltext": "Taburet AM, Piketty C, Chazallon C, et al. Interactions between atazanavir-ritonavir and tenofovir in heavily pretreated human immunodeficiency virus-infected patients. Antimicrob Agents Chemother. 2004 Jun; 48 (6): 2091\u20132096.",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2004"},
                            "ref-title": {"ref-titletext": "Interactions between atazanavir-ritonavir and tenofovir in heavily pretreated human immunodeficiency virus-infected patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0028",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "2542502584",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "48",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "2091",
                                    "@last": "2096"
                                }
                            },
                            "ref-text": "Jun",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Taburet",
                                        "ce:indexed-name": "Taburet A.M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Piketty",
                                        "ce:indexed-name": "Piketty C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Chazallon",
                                        "ce:indexed-name": "Chazallon C."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Antimicrob Agents Chemother"
                        },
                        "ce:source-text": "Taburet AM, Piketty C, Chazallon C, et al. Interactions between atazanavir-ritonavir and tenofovir in heavily pretreated human immunodeficiency virus-infected patients. Antimicrob Agents Chemother. 2004 Jun; 48 (6): 2091\u20132096."
                    },
                    {
                        "ref-fulltext": "Dailly E, Tribut O, Tattevin P, et al. Influence of tenofovir, nevirapine and efavirenz on ritonavir-boosted atazanavir pharmacokinetics in HIV-infected patients. Eur J Clin Pharmacol. 2006 Jul; 62 (7): 523\u2013526.",
                        "@id": "29",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Influence of tenofovir, nevirapine and efavirenz on ritonavir-boosted atazanavir pharmacokinetics in HIV-infected patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0029",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "33745713170",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "62",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "523",
                                    "@last": "526"
                                }
                            },
                            "ref-text": "Jul",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Dailly",
                                        "ce:indexed-name": "Dailly E."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "O.",
                                        "@_fa": "true",
                                        "ce:surname": "Tribut",
                                        "ce:indexed-name": "Tribut O."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Tattevin",
                                        "ce:indexed-name": "Tattevin P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Eur J Clin Pharmacol"
                        },
                        "ce:source-text": "Dailly E, Tribut O, Tattevin P, et al. Influence of tenofovir, nevirapine and efavirenz on ritonavir-boosted atazanavir pharmacokinetics in HIV-infected patients. Eur J Clin Pharmacol. 2006 Jul; 62 (7): 523\u2013526."
                    },
                    {
                        "ref-fulltext": "Stohr W, Back D, Dunn D, et al. Factors influencing lopinavir and atazanavir plasma concentration. J Antimicrob Chemother. 2010 Jan; 65 (1): 129\u2013137.",
                        "@id": "30",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Factors influencing lopinavir and atazanavir plasma concentration"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0030",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "77950345853",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "65",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "129",
                                    "@last": "137"
                                }
                            },
                            "ref-text": "Jan",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "W.",
                                        "@_fa": "true",
                                        "ce:surname": "Stohr",
                                        "ce:indexed-name": "Stohr W."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Back",
                                        "ce:indexed-name": "Back D."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Dunn",
                                        "ce:indexed-name": "Dunn D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Antimicrob Chemother"
                        },
                        "ce:source-text": "Stohr W, Back D, Dunn D, et al. Factors influencing lopinavir and atazanavir plasma concentration. J Antimicrob Chemother. 2010 Jan; 65 (1): 129\u2013137."
                    },
                    {
                        "ref-fulltext": "Venuto CS, Mollan K, Ma Q, et al. Sex differences in atazanavir pharmacokinetics and associations with time to clinical events: AIDS clinical trials group study A5202. J Antimicrob Chemother. 2014 Dec; 69 (12): 3300\u20133310.",
                        "@id": "31",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Sex differences in atazanavir pharmacokinetics and associations with time to clinical events: AIDS clinical trials group study A5202"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0031",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84960146946",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "69",
                                    "@issue": "12"
                                },
                                "pagerange": {
                                    "@first": "3300",
                                    "@last": "3310"
                                }
                            },
                            "ref-text": "Dec",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Venuto",
                                        "ce:indexed-name": "Venuto C.S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Mollan",
                                        "ce:indexed-name": "Mollan K."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Q.",
                                        "@_fa": "true",
                                        "ce:surname": "Ma",
                                        "ce:indexed-name": "Ma Q."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Antimicrob Chemother"
                        },
                        "ce:source-text": "Venuto CS, Mollan K, Ma Q, et al. Sex differences in atazanavir pharmacokinetics and associations with time to clinical events: AIDS clinical trials group study A5202. J Antimicrob Chemother. 2014 Dec; 69 (12): 3300\u20133310."
                    },
                    {
                        "ref-fulltext": "Goutelle S, Baudry T, Gagnieu MC, et al. Pharmacokinetic-pharmacodynamic modeling of unboosted atazanavir in a cohort of stable HIV-infected patients. Antimicrob Agents Chemother. 2013 Jan; 57 (1): 517\u2013523.",
                        "@id": "32",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Pharmacokinetic-pharmacodynamic modeling of unboosted atazanavir in a cohort of stable HIV-infected patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0032",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84872029110",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "57",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "517",
                                    "@last": "523"
                                }
                            },
                            "ref-text": "Jan",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Goutelle",
                                        "ce:indexed-name": "Goutelle S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Baudry",
                                        "ce:indexed-name": "Baudry T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Gagnieu",
                                        "ce:indexed-name": "Gagnieu M.C."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Antimicrob Agents Chemother"
                        },
                        "ce:source-text": "Goutelle S, Baudry T, Gagnieu MC, et al. Pharmacokinetic-pharmacodynamic modeling of unboosted atazanavir in a cohort of stable HIV-infected patients. Antimicrob Agents Chemother. 2013 Jan; 57 (1): 517\u2013523."
                    },
                    {
                        "ref-fulltext": "Barco E, Nóvoa S. The pharmacogenetics of HIV treatment: a practical clinical approach. J Pharmacogenomics Pharmacoproteomics. 2013; 4: 116.",
                        "@id": "33",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "The pharmacogenetics of HIV treatment: a practical clinical approach"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0033",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84982751764",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "4"},
                                "pagerange": {"@first": "116"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Barco",
                                    "ce:indexed-name": "Barco E."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Nóvoa",
                                    "ce:indexed-name": "Novoa S."
                                }
                            ]},
                            "ref-sourcetitle": "J Pharmacogenomics Pharmacoproteomics"
                        },
                        "ce:source-text": "Barco E, Nóvoa S. The pharmacogenetics of HIV treatment: a practical clinical approach. J Pharmacogenomics Pharmacoproteomics. 2013; 4: 116."
                    },
                    {
                        "ref-fulltext": "Calcagno A, Cusato J, D\u2019Avolio A, et al. Genetic polymorphisms affecting the pharmacokinetics of antiretroviral drugs. Clin Pharmacokinet. 2017 Apr; 56 (4): 355\u2013369.",
                        "@id": "34",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Genetic polymorphisms affecting the pharmacokinetics of antiretroviral drugs"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0034",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84988418816",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "56",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "355",
                                    "@last": "369"
                                }
                            },
                            "ref-text": "Apr",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Calcagno",
                                        "ce:indexed-name": "Calcagno A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Cusato",
                                        "ce:indexed-name": "Cusato J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "D\u2019Avolio",
                                        "ce:indexed-name": "D'Avolio A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Pharmacokinet"
                        },
                        "ce:source-text": "Calcagno A, Cusato J, D\u2019Avolio A, et al. Genetic polymorphisms affecting the pharmacokinetics of antiretroviral drugs. Clin Pharmacokinet. 2017 Apr; 56 (4): 355\u2013369."
                    },
                    {
                        "ref-fulltext": "Avihingsanon A, van der Lugt J, Kerr SJ, et al. A low dose of ritonavir-boosted atazanavir provides adequate pharmacokinetic parameters in HIV-1-infected Thai adults. Clin Pharmacol Ther. 2009 Apr; 85 (4): 402\u2013408.",
                        "@id": "35",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "A low dose of ritonavir-boosted atazanavir provides adequate pharmacokinetic parameters in HIV-1-infected Thai adults"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0035",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "62649107112",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "85",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "402",
                                    "@last": "408"
                                }
                            },
                            "ref-text": "Apr",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Avihingsanon",
                                        "ce:indexed-name": "Avihingsanon A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "van der Lugt",
                                        "ce:indexed-name": "van der Lugt J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Kerr",
                                        "ce:indexed-name": "Kerr S.J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Pharmacol Ther"
                        },
                        "ce:source-text": "Avihingsanon A, van der Lugt J, Kerr SJ, et al. A low dose of ritonavir-boosted atazanavir provides adequate pharmacokinetic parameters in HIV-1-infected Thai adults. Clin Pharmacol Ther. 2009 Apr; 85 (4): 402\u2013408."
                    },
                    {
                        "ref-fulltext": "Avihingsanon A, Apornpong T, Kerr S, et al. Low-dose ritonavir-boosted atazanavir (200/100 mg) maintained a high virological efficacy up to 4 years in treatment-experienced HIV-1 infected adults: a prospective cohort study from Asia. J AIDS Clin Res. 2015; 6 (5). DOI: 10.4172/2155-6113.1000460.",
                        "@id": "36",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Low-dose ritonavir-boosted atazanavir (200/100 mg) maintained a high virological efficacy up to 4 years in treatment-experienced HIV-1 infected adults: a prospective cohort study from Asia"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.4172/2155-6113.1000460",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "cit0036",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84994880704",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {
                                "@volume": "6",
                                "@issue": "5"
                            }},
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Avihingsanon",
                                        "ce:indexed-name": "Avihingsanon A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Apornpong",
                                        "ce:indexed-name": "Apornpong T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Kerr",
                                        "ce:indexed-name": "Kerr S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J AIDS Clin Res"
                        },
                        "ce:source-text": "Avihingsanon A, Apornpong T, Kerr S, et al. Low-dose ritonavir-boosted atazanavir (200/100 mg) maintained a high virological efficacy up to 4 years in treatment-experienced HIV-1 infected adults: a prospective cohort study from Asia. J AIDS Clin Res. 2015; 6 (5). DOI: 10.4172/2155-6113.1000460."
                    },
                    {
                        "ref-fulltext": "Bunupuradah T, Kiertiburanakul S, and Avihingsanon A, et al. Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): a randomised, open-label, non-inferiority trial. Lancet HIV. 2016 Aug; 3 (8): e343\u2013350.",
                        "@id": "37",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): a randomised, open-label, non-inferiority trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0037",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84969667316",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "3",
                                    "@issue": "8"
                                },
                                "pagerange": {
                                    "@first": "e343",
                                    "@last": "e350"
                                }
                            },
                            "ref-text": "Aug, and",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Bunupuradah",
                                        "ce:indexed-name": "Bunupuradah T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Kiertiburanakul",
                                        "ce:indexed-name": "Kiertiburanakul S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Avihingsanon",
                                        "ce:indexed-name": "Avihingsanon A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet HIV"
                        },
                        "ce:source-text": "Bunupuradah T, Kiertiburanakul S, and Avihingsanon A, et al. Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): a randomised, open-label, non-inferiority trial. Lancet HIV. 2016 Aug; 3 (8): e343\u2013350."
                    },
                    {
                        "ref-fulltext": "Burger D, Teulen M, Eerland J, et al. The international interlaboratory quality control program for measurement of antiretroviral drugs in plasma: a global proficiency testing program. Ther Drug Monit. 2011 Apr; 33 (2): 239\u2013243.",
                        "@id": "38",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "The international interlaboratory quality control program for measurement of antiretroviral drugs in plasma: a global proficiency testing program"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0038",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "79953216672",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "33",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "239",
                                    "@last": "243"
                                }
                            },
                            "ref-text": "Apr",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Burger",
                                        "ce:indexed-name": "Burger D."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Teulen",
                                        "ce:indexed-name": "Teulen M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Eerland",
                                        "ce:indexed-name": "Eerland J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ther Drug Monit"
                        },
                        "ce:source-text": "Burger D, Teulen M, Eerland J, et al. The international interlaboratory quality control program for measurement of antiretroviral drugs in plasma: a global proficiency testing program. Ther Drug Monit. 2011 Apr; 33 (2): 239\u2013243."
                    },
                    {
                        "ref-fulltext": "QIAamp® DNA mini and blood mini handbook [internet]. QIAGEN; 2016 [cited 2017 Nov]. Available from: file:///C:/Users/Administrator/Downloads/HB-0329-004-1102728-HB-QIAamp-DNA-Mini-Blood-Mini-0516-WW%20(1).pdf",
                        "@id": "39",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-website": {"ce:e-address": {
                                "$": "http://file:///C:/Users/Administrator/Downloads/HB-0329-004-1102728-HB-QIAamp-DNA-Mini-Blood-Mini-0516-WW%20(1).pdf",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "QIAamp® DNA mini and blood mini handbook [internet]"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0039",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85120035019",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "cited, 2017 Nov, Available from",
                            "ref-sourcetitle": "QIAGEN"
                        },
                        "ce:source-text": "QIAamp® DNA mini and blood mini handbook [internet]. QIAGEN; 2016 [cited 2017 Nov]. Available from: file:///C:/Users/Administrator/Downloads/HB-0329-004-1102728-HB-QIAamp-DNA-Mini-Blood-Mini-0516-WW%20(1).pdf"
                    },
                    {
                        "ref-fulltext": "Livak KJ. Allelic discrimination using fluorogenic probes and the 5\u2032 nuclease assay. Genet Anal. 1999 Feb; 14 (5\u20136): 143\u2013149.",
                        "@id": "40",
                        "ref-info": {
                            "ref-title": {"ref-titletext": "Allelic discrimination using fluorogenic probes and the 5\u2032 nuclease assay"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0040",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0033006003",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "14",
                                    "@issue": "5-6"
                                },
                                "pagerange": {
                                    "@first": "143",
                                    "@last": "149"
                                }
                            },
                            "ref-text": "1999 Feb",
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "K.J.",
                                "@_fa": "true",
                                "ce:surname": "Livak",
                                "ce:indexed-name": "Livak K.J."
                            }]},
                            "ref-sourcetitle": "Genet Anal"
                        },
                        "ce:source-text": "Livak KJ. Allelic discrimination using fluorogenic probes and the 5\u2032 nuclease assay. Genet Anal. 1999 Feb; 14 (5\u20136): 143\u2013149."
                    },
                    {
                        "ref-fulltext": "Boekmann AJ, Sheiner LB, Beal SL., et al. NONMEM user\u2019s guide, part V: introductory guide. San Francisco (CA): NONMEM Project Group: University of California; 1994.",
                        "@id": "41",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1994"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0041",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0003747347",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "San Francisco (CA): NONMEM Project Group: University of California",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Boekmann",
                                        "ce:indexed-name": "Boekmann A.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "L.B.",
                                        "@_fa": "true",
                                        "ce:surname": "Sheiner",
                                        "ce:indexed-name": "Sheiner L.B."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Beal",
                                        "ce:indexed-name": "Beal S.L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "NONMEM user\u2019s guide, part V: introductory guide"
                        },
                        "ce:source-text": "Boekmann AJ, Sheiner LB, Beal SL., et al. NONMEM user\u2019s guide, part V: introductory guide. San Francisco (CA): NONMEM Project Group: University of California; 1994."
                    },
                    {
                        "ref-fulltext": "Keizer RJ, Karlsson MO, Hooker A., et al. Modeling and simulation workbench for NONMEM: tutorial on Pirana, PsN, and Xpose. CPT Pharmacometrics Syst Pharmacol. 2013 Jun; 26 (2): 1\u20139.",
                        "@id": "42",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Modeling and simulation workbench for NONMEM: tutorial on Pirana, PsN, and Xpose"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0042",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84881127134",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "26",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "1",
                                    "@last": "9"
                                }
                            },
                            "ref-text": "Jun",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Keizer",
                                        "ce:indexed-name": "Keizer R.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.O.",
                                        "@_fa": "true",
                                        "ce:surname": "Karlsson",
                                        "ce:indexed-name": "Karlsson M.O."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Hooker",
                                        "ce:indexed-name": "Hooker A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "CPT Pharmacometrics Syst Pharmacol"
                        },
                        "ce:source-text": "Keizer RJ, Karlsson MO, Hooker A., et al. Modeling and simulation workbench for NONMEM: tutorial on Pirana, PsN, and Xpose. CPT Pharmacometrics Syst Pharmacol. 2013 Jun; 26 (2): 1\u20139."
                    },
                    {
                        "ref-fulltext": "Jonsson EN, Karlsson MO. Xpose\u2013an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM. Comput Methods Programs Biomed. 1999 Jan; 58 (1): 51\u201364.",
                        "@id": "43",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1999"},
                            "ref-title": {"ref-titletext": "Xpose\u2013an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0043",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0002322365",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "58",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "51",
                                    "@last": "64"
                                }
                            },
                            "ref-text": "Jan",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "E.N.",
                                    "@_fa": "true",
                                    "ce:surname": "Jonsson",
                                    "ce:indexed-name": "Jonsson E.N."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.O.",
                                    "@_fa": "true",
                                    "ce:surname": "Karlsson",
                                    "ce:indexed-name": "Karlsson M.O."
                                }
                            ]},
                            "ref-sourcetitle": "Comput Methods Programs Biomed"
                        },
                        "ce:source-text": "Jonsson EN, Karlsson MO. Xpose\u2013an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM. Comput Methods Programs Biomed. 1999 Jan; 58 (1): 51\u201364."
                    },
                    {
                        "ref-fulltext": "Zhang L, Beal SL, Sheiner LB., et al. Simultaneous vs. sequential analysis for population PK/PD data I: best-case performance. J Pharmacokinet Pharmacodyn. 2003 Dec; 30 (6): 387\u2013404.",
                        "@id": "44",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "Simultaneous vs. sequential analysis for population PK/PD data I: best-case performance"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0044",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "1242269757",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "30",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "387",
                                    "@last": "404"
                                }
                            },
                            "ref-text": "Dec",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Zhang",
                                        "ce:indexed-name": "Zhang L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Beal",
                                        "ce:indexed-name": "Beal S.L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L.B.",
                                        "@_fa": "true",
                                        "ce:surname": "Sheiner",
                                        "ce:indexed-name": "Sheiner L.B."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Pharmacokinet Pharmacodyn"
                        },
                        "ce:source-text": "Zhang L, Beal SL, Sheiner LB., et al. Simultaneous vs. sequential analysis for population PK/PD data I: best-case performance. J Pharmacokinet Pharmacodyn. 2003 Dec; 30 (6): 387\u2013404."
                    },
                    {
                        "ref-fulltext": "Ette EI, Williams PJ, Kim YH, et al. Model appropriateness and population pharmacokinetic modeling. J Clin Pharmacol. 2003 Jun; 43 (6): 610\u2013623.",
                        "@id": "45",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "Model appropriateness and population pharmacokinetic modeling"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0045",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0038243538",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "43",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "610",
                                    "@last": "623"
                                }
                            },
                            "ref-text": "Jun",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E.I.",
                                        "@_fa": "true",
                                        "ce:surname": "Ette",
                                        "ce:indexed-name": "Ette E.I."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Williams",
                                        "ce:indexed-name": "Williams P.J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Y.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Kim",
                                        "ce:indexed-name": "Kim Y.H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Pharmacol"
                        },
                        "ce:source-text": "Ette EI, Williams PJ, Kim YH, et al. Model appropriateness and population pharmacokinetic modeling. J Clin Pharmacol. 2003 Jun; 43 (6): 610\u2013623."
                    },
                    {
                        "ref-fulltext": "Jadhav PR, Gobburu JV. A new equivalence based metric for predictive check to qualify mixed-effects models. AAPS J. 2005; 7 (3): E523\u2013E531.",
                        "@id": "46",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "A new equivalence based metric for predictive check to qualify mixed-effects models"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0046",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "33644813010",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "7",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "E523",
                                    "@last": "E531"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "P.R.",
                                    "@_fa": "true",
                                    "ce:surname": "Jadhav",
                                    "ce:indexed-name": "Jadhav P.R."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J.V.",
                                    "@_fa": "true",
                                    "ce:surname": "Gobburu",
                                    "ce:indexed-name": "Gobburu J.V."
                                }
                            ]},
                            "ref-sourcetitle": "AAPS J"
                        },
                        "ce:source-text": "Jadhav PR, Gobburu JV. A new equivalence based metric for predictive check to qualify mixed-effects models. AAPS J. 2005; 7 (3): E523\u2013E531."
                    },
                    {
                        "ref-fulltext": "Dickinson L, Boffito M, Back D, et al. Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected patients and healthy volunteers. J Antimicrob Chemother. 2009 Jun; 63 (6): 1233\u20131243.",
                        "@id": "47",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected patients and healthy volunteers"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0047",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "65749113553",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "63",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "1233",
                                    "@last": "1243"
                                }
                            },
                            "ref-text": "Jun",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Dickinson",
                                        "ce:indexed-name": "Dickinson L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Boffito",
                                        "ce:indexed-name": "Boffito M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Back",
                                        "ce:indexed-name": "Back D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Antimicrob Chemother"
                        },
                        "ce:source-text": "Dickinson L, Boffito M, Back D, et al. Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected patients and healthy volunteers. J Antimicrob Chemother. 2009 Jun; 63 (6): 1233\u20131243."
                    },
                    {
                        "ref-fulltext": "Solas C, Gagnieu MC, Ravaux I, et al. Population pharmacokinetics of atazanavir in human immunodeficiency virus-infected patients. Ther Drug Monit. 2008 Dec; 30 (6): 670\u2013673.",
                        "@id": "48",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Population pharmacokinetics of atazanavir in human immunodeficiency virus-infected patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0048",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "57749095660",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "30",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "670",
                                    "@last": "673"
                                }
                            },
                            "ref-text": "Dec",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Solas",
                                        "ce:indexed-name": "Solas C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Gagnieu",
                                        "ce:indexed-name": "Gagnieu M.C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "I.",
                                        "@_fa": "true",
                                        "ce:surname": "Ravaux",
                                        "ce:indexed-name": "Ravaux I."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ther Drug Monit"
                        },
                        "ce:source-text": "Solas C, Gagnieu MC, Ravaux I, et al. Population pharmacokinetics of atazanavir in human immunodeficiency virus-infected patients. Ther Drug Monit. 2008 Dec; 30 (6): 670\u2013673."
                    },
                    {
                        "ref-fulltext": "Schipani A, Dickinson L, and Boffito M, et al. Simultaneous population pharmacokinetic modelling of atazanavir and ritonavir in HIV-infected adults and assessment of different dose reduction strategies. J Acquir Immune Defic Syndr. 2013 Jan 01; 62 (1): 60\u201366.",
                        "@id": "49",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Simultaneous population pharmacokinetic modelling of atazanavir and ritonavir in HIV-infected adults and assessment of different dose reduction strategies"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0049",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84872088973",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "62",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "60",
                                    "@last": "66"
                                }
                            },
                            "ref-text": "Jan, 01, and",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Schipani",
                                        "ce:indexed-name": "Schipani A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Dickinson",
                                        "ce:indexed-name": "Dickinson L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Boffito",
                                        "ce:indexed-name": "Boffito M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Acquir Immune Defic Syndr"
                        },
                        "ce:source-text": "Schipani A, Dickinson L, and Boffito M, et al. Simultaneous population pharmacokinetic modelling of atazanavir and ritonavir in HIV-infected adults and assessment of different dose reduction strategies. J Acquir Immune Defic Syndr. 2013 Jan 01; 62 (1): 60\u201366."
                    },
                    {
                        "ref-fulltext": "Molto J, Estevez JA, Miranda C, et al. Population pharmacokinetic modelling of the changes in atazanavir plasma clearance caused by ritonavir plasma concentrations in HIV-1 infected patients. Br J Clin Pharmacol. 2016 Dec; 82 (6): 1528\u20131538.",
                        "@id": "50",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Population pharmacokinetic modelling of the changes in atazanavir plasma clearance caused by ritonavir plasma concentrations in HIV-1 infected patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0050",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84987994875",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "82",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "1528",
                                    "@last": "1538"
                                }
                            },
                            "ref-text": "Dec",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Molto",
                                        "ce:indexed-name": "Molto J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Estevez",
                                        "ce:indexed-name": "Estevez J.A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Miranda",
                                        "ce:indexed-name": "Miranda C."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Br J Clin Pharmacol"
                        },
                        "ce:source-text": "Molto J, Estevez JA, Miranda C, et al. Population pharmacokinetic modelling of the changes in atazanavir plasma clearance caused by ritonavir plasma concentrations in HIV-1 infected patients. Br J Clin Pharmacol. 2016 Dec; 82 (6): 1528\u20131538."
                    },
                    {
                        "ref-fulltext": "Solas C, Simon N, Drogoul MP, et al. Minimal effect of MDR1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of indinavir in HIV-infected patients. Br J Clin Pharmacol. 2007 Sep; 64 (3): 353\u2013362.",
                        "@id": "51",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Minimal effect of MDR1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of indinavir in HIV-infected patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0051",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "34548036943",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "64",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "353",
                                    "@last": "362"
                                }
                            },
                            "ref-text": "Sep",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Solas",
                                        "ce:indexed-name": "Solas C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Simon",
                                        "ce:indexed-name": "Simon N."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.P.",
                                        "@_fa": "true",
                                        "ce:surname": "Drogoul",
                                        "ce:indexed-name": "Drogoul M.P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Br J Clin Pharmacol"
                        },
                        "ce:source-text": "Solas C, Simon N, Drogoul MP, et al. Minimal effect of MDR1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of indinavir in HIV-infected patients. Br J Clin Pharmacol. 2007 Sep; 64 (3): 353\u2013362."
                    },
                    {
                        "ref-fulltext": "Gandhi M, Aweeka F, Greenblatt RM, et al. Sex differences in pharmacokinetics and pharmacodynamics. Annu Rev Pharmacol Toxicol. 2004; 44 (1): 499\u2013523.",
                        "@id": "52",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2004"},
                            "ref-title": {"ref-titletext": "Sex differences in pharmacokinetics and pharmacodynamics"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0052",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "1342302371",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "44",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "499",
                                    "@last": "523"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Gandhi",
                                        "ce:indexed-name": "Gandhi M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Aweeka",
                                        "ce:indexed-name": "Aweeka F."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Greenblatt",
                                        "ce:indexed-name": "Greenblatt R.M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Annu Rev Pharmacol Toxicol"
                        },
                        "ce:source-text": "Gandhi M, Aweeka F, Greenblatt RM, et al. Sex differences in pharmacokinetics and pharmacodynamics. Annu Rev Pharmacol Toxicol. 2004; 44 (1): 499\u2013523."
                    },
                    {
                        "ref-fulltext": "Ofotokun I, Chuck SK, Hitti JE., et al. Antiretroviral pharmacokinetic profile: a review of sex differences. Gend Med. 2007 Jun; 4 (2): 106\u2013119.",
                        "@id": "53",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Antiretroviral pharmacokinetic profile: a review of sex differences"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0053",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "34547879291",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "4",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "106",
                                    "@last": "119"
                                }
                            },
                            "ref-text": "Jun",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "I.",
                                        "@_fa": "true",
                                        "ce:surname": "Ofotokun",
                                        "ce:indexed-name": "Ofotokun I."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.K.",
                                        "@_fa": "true",
                                        "ce:surname": "Chuck",
                                        "ce:indexed-name": "Chuck S.K."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.E.",
                                        "@_fa": "true",
                                        "ce:surname": "Hitti",
                                        "ce:indexed-name": "Hitti J.E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gend Med"
                        },
                        "ce:source-text": "Ofotokun I, Chuck SK, Hitti JE., et al. Antiretroviral pharmacokinetic profile: a review of sex differences. Gend Med. 2007 Jun; 4 (2): 106\u2013119."
                    },
                    {
                        "ref-fulltext": "Zhang C, Denti P, Decloedt EH, et al. Model-based evaluation of the pharmacokinetic differences between adults and children for lopinavir and ritonavir in combination with rifampicin. Br J Clin Pharmacol. 2013 Nov; 76 (5): 741\u2013751.",
                        "@id": "54",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Model-based evaluation of the pharmacokinetic differences between adults and children for lopinavir and ritonavir in combination with rifampicin"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0054",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84886911648",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "76",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "741",
                                    "@last": "751"
                                }
                            },
                            "ref-text": "Nov",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Zhang",
                                        "ce:indexed-name": "Zhang C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Denti",
                                        "ce:indexed-name": "Denti P."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Decloedt",
                                        "ce:indexed-name": "Decloedt E.H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Br J Clin Pharmacol"
                        },
                        "ce:source-text": "Zhang C, Denti P, Decloedt EH, et al. Model-based evaluation of the pharmacokinetic differences between adults and children for lopinavir and ritonavir in combination with rifampicin. Br J Clin Pharmacol. 2013 Nov; 76 (5): 741\u2013751."
                    },
                    {
                        "ref-fulltext": "Hsu A, Granneman GR, Witt G, et al. Multiple-dose pharmacokinetics of ritonavir in human immunodeficiency virus-infected subjects. Antimicrob Agents Chemother. 1997 May; 41 (5): 898\u2013905.",
                        "@id": "55",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1997"},
                            "ref-title": {"ref-titletext": "Multiple-dose pharmacokinetics of ritonavir in human immunodeficiency virus-infected subjects"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0055",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0030896237",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "41",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "898",
                                    "@last": "905"
                                }
                            },
                            "ref-text": "May",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Hsu",
                                        "ce:indexed-name": "Hsu A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G.R.",
                                        "@_fa": "true",
                                        "ce:surname": "Granneman",
                                        "ce:indexed-name": "Granneman G.R."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Witt",
                                        "ce:indexed-name": "Witt G."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Antimicrob Agents Chemother"
                        },
                        "ce:source-text": "Hsu A, Granneman GR, Witt G, et al. Multiple-dose pharmacokinetics of ritonavir in human immunodeficiency virus-infected subjects. Antimicrob Agents Chemother. 1997 May; 41 (5): 898\u2013905."
                    },
                    {
                        "ref-fulltext": "Castillo-Mancilla JR, Aquilante CL, Wempe MF, et al. Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS clinical trials group (ACTG) PEARLS study (NWCS 342). J Antimicrob Chemother. 2016 Jun; 71 (6): 1609\u20131618.",
                        "@id": "56",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS clinical trials group (ACTG) PEARLS study (NWCS 342)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cit0056",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84973349104",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "71",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "1609",
                                    "@last": "1618"
                                }
                            },
                            "ref-text": "Jun",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.R.",
                                        "@_fa": "true",
                                        "ce:surname": "Castillo-Mancilla",
                                        "ce:indexed-name": "Castillo-Mancilla J.R."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Aquilante",
                                        "ce:indexed-name": "Aquilante C.L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.F.",
                                        "@_fa": "true",
                                        "ce:surname": "Wempe",
                                        "ce:indexed-name": "Wempe M.F."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Antimicrob Chemother"
                        },
                        "ce:source-text": "Castillo-Mancilla JR, Aquilante CL, Wempe MF, et al. Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS clinical trials group (ACTG) PEARLS study (NWCS 342). J Antimicrob Chemother. 2016 Jun; 71 (6): 1609\u20131618."
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Phayao",
            "@id": "60114221",
            "affilname": "University of Phayao",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60114221",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60031780",
            "affilname": "Thai Red Cross Agency",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031780",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Khon Kaen",
            "@id": "60026046",
            "affilname": "Faculty of Medicine, Khon Kaen University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026046",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60015887",
            "affilname": "Faculty of Medicine Ramathibodi Hospital, Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015887",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Minneapolis",
            "@id": "60015427",
            "affilname": "College of Pharmacy",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015427",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Chaing Mai",
            "@id": "60000881",
            "affilname": "Chiang Mai University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881",
            "affiliation-country": "Thailand"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85120038365",
        "dc:description": "Background: This population pharmacokinetic\u2013pharmacogenetic study aimed to investigate the optimal dose of RTV-boosted ATV (ATV/RTV) for Thai adult HIV-infected patients. Methods: A total of 1460 concentrations of ATV and RTV from 544 patients receiving an ATV/RTV-based regimen were analyzed. The CYP3A5 6986 A > G, ABCB1 3435 C > T, ABCB1 2677 G > T, SLCO1B1 521 T > C, and NR1I2 63396 C > T were genotyped. A population pharmacokinetic model was performed using a nonlinear mixed-effect model (NONMEM®). Monte Carlo simulations were conducted to compare the percentages of patients achieving the therapeutic range of ATV through concentrations (Ctrough). Results: The apparent oral clearance of ATV (CL/FATV) without RTV was 7.69 L/h with interindividual variability (IIV) of 28.7%. Patients with CYP3A5 6986 GG had a 7.1% lower CL/FATV than those with AA or AG genotype. The CL/FATV decreased by 10.8% for females compared with males. Simulation results showed higher percentages (~70%) of patient receiving doses of 200/100 or 200/50 mg achieved the target ATV Ctrough, while more patients (~40%) receiving a standard dose (300/100 mg) had ATV Ctrough above this target. Conclusions: Both CYP3A5 6986 A > G and female decreased CL/FATV in Thai HIV-infected patients. Simulations supported that the reduced dose of ATV/RTV was sufficient to achieve the target concentration for Thai population.",
        "pubmed-id": "34727835",
        "prism:coverDate": "2022-01-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85120038365",
        "dc:creator": {"author": [{
            "ce:given-name": "Noppaket",
            "preferred-name": {
                "ce:given-name": "Noppaket",
                "ce:initials": "N.",
                "ce:surname": "Singkham",
                "ce:indexed-name": "Singkham N."
            },
            "@seq": "1",
            "ce:initials": "N.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60000881",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881"
                },
                {
                    "@id": "60114221",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60114221"
                }
            ],
            "ce:surname": "Singkham",
            "@auid": "55524284500",
            "author-url": "https://api.elsevier.com/content/author/author_id/55524284500",
            "ce:indexed-name": "Singkham N."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85120038365"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85120038365&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85120038365&origin=inward"
            }
        ],
        "source-id": "10300153301",
        "citedby-count": "0",
        "prism:volume": "15",
        "subtype": "ar",
        "dc:title": "Pharmacogenetics-based population pharmacokinetic analysis for dose optimization of ritonavir-boosted atazanavir in Thai adult HIV-infected patients",
        "openaccess": "0",
        "prism:issn": "17512441 17512433",
        "publishercopyright": "© 2021 Informa UK Limited, trading as Taylor & Francis Group.",
        "prism:issueIdentifier": "1",
        "subtypeDescription": "Article",
        "prism:publicationName": "Expert Review of Clinical Pharmacology",
        "prism:pageRange": "99-108",
        "prism:endingPage": "108",
        "openaccessFlag": "false",
        "prism:doi": "10.1080/17512433.2022.2000858",
        "prism:startingPage": "99",
        "dc:identifier": "SCOPUS_ID:85120038365",
        "dc:publisher": "Taylor and Francis Ltd."
    },
    "idxterms": {"mainterm": [
        {
            "$": "Adult",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Anti-HIV Agents",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Atazanavir Sulfate",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Female",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "HIV Infections",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Liver-Specific Organic Anion Transporter 1",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Male",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Pharmacogenetics",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Ritonavir",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Thailand",
            "@weight": "b",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "Atazanavir"
        },
        {
            "@_fa": "true",
            "$": "Pharmacogenetics"
        },
        {
            "@_fa": "true",
            "$": "Population Pharmacokinetics"
        },
        {
            "@_fa": "true",
            "$": "Ritonavir"
        },
        {
            "@_fa": "true",
            "$": "Thai patient"
        }
    ]},
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Pharmacology, Toxicology and Pharmaceutics (all)",
            "@code": "3000",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ]},
    "authors": {"author": [
        {
            "ce:given-name": "Noppaket",
            "preferred-name": {
                "ce:given-name": "Noppaket",
                "ce:initials": "N.",
                "ce:surname": "Singkham",
                "ce:indexed-name": "Singkham N."
            },
            "@seq": "1",
            "ce:initials": "N.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60000881",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881"
                },
                {
                    "@id": "60114221",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60114221"
                }
            ],
            "ce:surname": "Singkham",
            "@auid": "55524284500",
            "author-url": "https://api.elsevier.com/content/author/author_id/55524284500",
            "ce:indexed-name": "Singkham N."
        },
        {
            "ce:given-name": "Anchalee",
            "preferred-name": {
                "ce:given-name": "Anchalee",
                "ce:initials": "A.",
                "ce:surname": "Avihingsanon",
                "ce:indexed-name": "Avihingsanon A."
            },
            "@seq": "2",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60031780",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031780"
                },
                {
                    "@id": "60002620",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
                }
            ],
            "ce:surname": "Avihingsanon",
            "@auid": "57196347321",
            "author-url": "https://api.elsevier.com/content/author/author_id/57196347321",
            "ce:indexed-name": "Avihingsanon A."
        },
        {
            "ce:given-name": "Richard C",
            "preferred-name": {
                "ce:given-name": "Richard C.",
                "ce:initials": "R.C.",
                "ce:surname": "Brundage",
                "ce:indexed-name": "Brundage R.C."
            },
            "@seq": "3",
            "ce:initials": "R.C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60015427",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015427"
            },
            "ce:surname": "Brundage",
            "@auid": "7003818004",
            "author-url": "https://api.elsevier.com/content/author/author_id/7003818004",
            "ce:indexed-name": "Brundage R.C."
        },
        {
            "ce:given-name": "Angela K",
            "preferred-name": {
                "ce:given-name": "Angela K.",
                "ce:initials": "A.K.",
                "ce:surname": "Birnbaum",
                "ce:indexed-name": "Birnbaum A.K."
            },
            "@seq": "4",
            "ce:initials": "A.K.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60015427",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015427"
            },
            "ce:surname": "Birnbaum",
            "@auid": "7007017778",
            "author-url": "https://api.elsevier.com/content/author/author_id/7007017778",
            "ce:indexed-name": "Birnbaum A.K."
        },
        {
            "ce:given-name": "Narukjaporn",
            "preferred-name": {
                "ce:given-name": "Narukjaporn",
                "ce:initials": "N.",
                "ce:surname": "Thammajaruk",
                "ce:indexed-name": "Thammajaruk N."
            },
            "@seq": "5",
            "ce:initials": "N.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60031780",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031780"
            },
            "ce:surname": "Thammajaruk",
            "@auid": "36451572800",
            "author-url": "https://api.elsevier.com/content/author/author_id/36451572800",
            "ce:indexed-name": "Thammajaruk N."
        },
        {
            "ce:given-name": "Kiat",
            "preferred-name": {
                "ce:given-name": "Kiat",
                "ce:initials": "K.",
                "ce:surname": "Ruxrungtham",
                "ce:indexed-name": "Ruxrungtham K."
            },
            "@seq": "6",
            "ce:initials": "K.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60031780",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031780"
                },
                {
                    "@id": "60002620",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
                }
            ],
            "ce:surname": "Ruxrungtham",
            "@auid": "7004208798",
            "author-url": "https://api.elsevier.com/content/author/author_id/7004208798",
            "ce:indexed-name": "Ruxrungtham K."
        },
        {
            "ce:given-name": "Torsak",
            "preferred-name": {
                "ce:given-name": "Torsak",
                "ce:initials": "T.",
                "ce:surname": "Bunupuradah",
                "ce:indexed-name": "Bunupuradah T."
            },
            "@seq": "7",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60031780",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031780"
            },
            "ce:surname": "Bunupuradah",
            "@auid": "15836773400",
            "author-url": "https://api.elsevier.com/content/author/author_id/15836773400",
            "ce:indexed-name": "Bunupuradah T."
        },
        {
            "ce:given-name": "Sasisopin",
            "preferred-name": {
                "ce:given-name": "Sasisopin",
                "ce:initials": "S.",
                "ce:surname": "Kiertiburanakul",
                "ce:indexed-name": "Kiertiburanakul S."
            },
            "@seq": "8",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60015887",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015887"
            },
            "ce:surname": "Kiertiburanakul",
            "@auid": "6506539792",
            "author-url": "https://api.elsevier.com/content/author/author_id/6506539792",
            "ce:indexed-name": "Kiertiburanakul S."
        },
        {
            "ce:given-name": "Ploenchan",
            "preferred-name": {
                "ce:given-name": "Ploenchan",
                "ce:initials": "P.",
                "ce:surname": "Chetchotisakd",
                "ce:indexed-name": "Chetchotisakd P."
            },
            "@seq": "9",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60026046",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026046"
            },
            "ce:surname": "Chetchotisakd",
            "@auid": "56992885200",
            "author-url": "https://api.elsevier.com/content/author/author_id/56992885200",
            "ce:indexed-name": "Chetchotisakd P."
        },
        {
            "ce:given-name": "Baralee",
            "preferred-name": {
                "ce:given-name": "Baralee",
                "ce:initials": "B.",
                "ce:surname": "Punyawudho",
                "ce:indexed-name": "Punyawudho B."
            },
            "@seq": "10",
            "ce:initials": "B.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60000881",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881"
            },
            "ce:surname": "Punyawudho",
            "@auid": "23976628300",
            "author-url": "https://api.elsevier.com/content/author/author_id/23976628300",
            "ce:indexed-name": "Punyawudho B."
        }
    ]}
}}